print
mail
Home
Media
In the News
Vectibix® in the News
Overview
Fact Sheets
Featured Content
Press Releases
Social Media
Media Contacts
In the News
Corporate News
Enbrel® in the News
ESAs in the News
Pipeline in the News
Prolia™ in the News
Neulasta® in the News
Nplate® in the News
Vectibix® in the News
XGEVA™ in the News
Virtual Press Kits
In the News
Vectibix® (panitumumab) in the News
Jan. 12, 2012
Amgen Modifies U.S. Prescribing Information for Vectibix® (panitumumab)
Feb. 4, 2011
Amgen Statement on Briefing Materials Prepared for February 8, 2011 Oncologic Drugs Advisory Committee Meeting
Jan. 6, 2011
Amgen to Participate in the February 8, 2011 Oncologic Drugs Advisory Committee (ODAC) Meeting on the Status of Accelerated Approvals
Nov. 8, 2010
Amgen Statement on Supplemental Biologics License Applications for Vectibix
Dec. 16, 2008
Amgen Comments on Discussion of
KRAS
Biomarker at Oncology Panel Meeting
Background Documents
Prescribing information for Vectibix®
Related Links
Products
Pipeline
Corporate Citizenship
Locations
footer
